Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma

Pawel Karol Mazur, Alexander Herner, Stephano S. Mello, Matthias Wirth, Simone Hausmann, Francisco J. Sánchez Rivera, Shane Lofgren, Timo Kuschma, Stephan A. Hahn, Deepak Vangala, Marija Trajkovic‐Arsic, Aayush Gupta, Irina Heid, Peter Benjamin Noël, Rickmer Braren, Mert Erkan, Jorg H. Kleeff, Bence Sipos, Leanne C. Sayles, Mathias F Heikenwälder, Elisabeth Heßmann, Volker Ellenrieder, Iréne Esposito, Tyler Jacks, James E. Bradner, and 7 more

View at source ↗PDF ↗Article399 citations
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.

Record

Archive ID
doi:10.1038/nm.3952
Published
Sep 21, 2015
Venue
Nature Medicine
DOI
10.1038/nm.3952
PubMed
26390243
Categories
Protein Degradation and Inhibitors
Provenance
openalex

Topics